Alosco, Michael L. https://orcid.org/0000-0002-8113-8428
Mejía Pérez, Jhony
Culhane, Julia E.
Shankar, Ranjani
Nowinski, Christopher J.
Bureau, Samantha
Mundada, Nidhi
Smith, Karen
Amuiri, Alinda
Asken, Breton
Groh, Jenna R.
Miner, Annalise
Pettway, Erika
Mosaheb, Sydney
Tripodis, Yorghos
Windon, Charles
Mercier, Gustavo
Stern, Robert A.
Grinberg, Lea T.
Soleimani-Meigooni, David N.
Christian, Bradley T.
Betthauser, Tobey J.
Stein, Thor D.
McKee, Ann C.
Mathis, Chester A.
Abrahamson, Eric E.
Ikonomovic, Milos D.
Johnson, Sterling C.
Mez, Jesse
La Joie, Renaud
Schonhaut, Daniel
Rabinovici, Gil D.
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (R21NS120629)
National Institute on Aging (P30AG072978, P30AG066468)
Article History
Received: 26 August 2024
Accepted: 30 January 2025
First Online: 25 February 2025
Declarations
:
: All sites received approval by their Institutional Review Board. Participants and/or their legally authorized representative provided written informed consent.
: Not applicable.
: C.J.N. is a volunteer member of the Mackey-White Committee of the National Football League Players Association for which he receives travel support; an advisor and options-holder with Oxeia Biopharmaceuticals, LLC, and StataDx; and has received travel support from the NFL, World Rugby, WWE, and AEW for lectures or conferences. CJN has served as an expert witness in cases related to concussion and CTE and is compensated for speaking appearances and serving on the Players Advocacy Committee for the NFL Concussion Settlement. CJN is employed by the Concussion Legacy Foundation, a 501(c)(3) non-profit which receives charitable donations. Michael L Alosco receives research support from Life Molecular Imaging Inc and Rainwater Charitable Foundation Inc. He also receives royalities from Oxford University Press Inc and received a single time honorarium from Michael J Fox Foundation for services unrelated to this study. Robert A. Stern has served as a consultant to Biogen and Lundbeck. He receives royalties for published neuropsychological tests from Psychological Assessment Resources, Inc. Milos D. Ikonomovic receives research support from NIA, Department of Veterans Affairs, and Avid Radiopharmaceuticals, Inc. SCJ has received prior research support from Cerveau Technologies for unrelated work and has served on advisory committees in the past three years for Enigma, AlzPath, and Roche Diagnostics. GDR receives research support from NIA, NINDS, Alzheimer’s Association, American College of Radiology, Rainwater Charitable Foundation, Alliance for Therapeutics in Neurodegeneration, Avid, GE Healthcare, LMI (all for New IDEAS); Genentech. He is a paid consultant (SAB, last 36 months) for Alector, Eli Lilly, Merck, Novo Norodisk, Roche. He is a paid DSMB member for Johnson & Johnson. He is Associate Editor of JAMA Neurology and JAMA.